RACK1 Acts as a Potential Tumor Promoter in Colorectal Cancer.
Xue-Yang LiYi HuNian-Shuang LiJian-Hua WanYin ZhuNong Hua LuPublished in: Gastroenterology research and practice (2019)
Our data indicated that RACK1, as an oncogene, markedly promoted the progression of CRC, which suggested that RACK1 is a potential therapeutic target for CRC management.